共 50 条
- [1] CHAL 36-Overview of pharmaceutical patent-ANDA litigation under the Hatch-Waxman Act[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 901 - 901Hasford, Justin J.
- [2] CHAL 2-High stakes patent litigation: A patently satisfying career choice[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238Hasford, Justin J.
- [3] CHAL 7 - The first step to ANDA litigation: Orange Book listability with the FDA[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237 : 944 - 944Irving, Thomas L.
- [4] CHAL 36 - Nanotechnology in consumer products: An update on regulatory responses and litigation[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237 : 921 - 921Kurfirst, Leonard S.
- [5] CHAL 10 - Pharmaceutical patent litigation[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237 : 949 - 949Ahmed, Ali I.
- [6] CHAL 12-Pharmaceutical patent litigation[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236Sokal, Allen
- [7] Litigation settlements, litigation stakes, and financial distress costs[J]. AUSTRALIAN JOURNAL OF MANAGEMENT, 2016, 41 (03) : 459 - 483Narayanamoorthy, Ganapathi S.Zhou, Hui
- [8] CHAL 13-Playing high stakes in intellectual property cases: Proving your damages[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236Price, Griffith B., Jr.
- [9] Predictors of verdict and punitive damages in high-stakes civil litigation[J]. BEHAVIORAL SCIENCES & THE LAW, 2008, 26 (02) : 167 - 186Vinson, Katherine V.Costanzo, Mark A.Berger, Dale E.
- [10] Compelled disclosure of scholarly research: Some comments on ''high stakes litigation''[J]. LAW AND CONTEMPORARY PROBLEMS, 1996, 59 (03) : 149 - 157Picou, JS